Screener
CONMED CNMD Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by CONMED in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The source filing: CONMED’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:13 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000816956-26-000102
| Line item | Three Months Ended / June 30, 2026 | Three Months Ended / June 30, 2025 | Six Months Ended / June 30, 2026 | Six Months Ended / June 30, 2025 |
|---|---|---|---|---|
| Selling and administrative expense | 145,553 | 136,021 | 287,252 | 284,868 |
| Research and development expense | 15,500 | 14,138 | 31,833 | 27,084 |
| Operating expenses | 161,053 | 150,159 | 319,085 | 311,952 |
| Income from operations | 36,405 | 38,161 | 61,820 | 54,119 |
| Interest expense | 7,883 | 7,824 | 14,943 | 16,110 |
| Other (income) / expense | (2,825) | 418 | (2,825) | 418 |
| Income before income taxes | 31,347 | 29,919 | 49,702 | 37,591 |
| Provision for income taxes | 8,276 | 8,498 | 12,803 | 10,134 |
Item 1. Financial Statements (unaudited)
FAQ
- What is CONMED's operating income?
- CONMED (CNMD) reported operating income of $36.41M in Q2 2026.
- How has CONMED's operating income changed year-over-year?
- CONMED's operating income decreased by 4.6% year-over-year, from $38.16M to $36.41M.
- What is the long-term trend for CONMED's operating income?
- Over 4 years (2021 to 2025), CONMED's operating income has grown at a -1.7% compound annual growth rate (CAGR), from $109.72M to $102.62M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.
Ask your AI about CONMED's operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude